(redirected from Reversible posterior leukoencephalopathy syndrome)
RPLEReversible Posterior Leukoencephalopathy Syndrome
References in periodicals archive ?
Presentation of reversible posterior leukoencephalopathy syndrome in patients on calcineurin inhibitors.
Anderson, "Reversible posterior leukoencephalopathy syndrome: a misnomer reviewed," Internal Medicine Journal, vol.
Sempere, "A reversible posterior leukoencephalopathy syndrome," Revista de Neurologia, vol.
Harik, "Reversible posterior leukoencephalopathy syndrome induced by RAF kinase inhibitor BAY 43-9006," Journal of Clinical Oncology, vol.
Atypical manifestations of reversible posterior leukoencephalopathy syndrome: findings on diffusion imaging and ADC mapping.
Clinical features of reversible posterior leukoencephalopathy syndrome in patients with systemic lupus erythematosus.
Reversible posterior leukoencephalopathy syndrome after repeat intermediate-dose cytarabine chemotherapy in a patient with acute myeloid leukemia.
Reversible posterior leukoencephalopathy syndrome (RPLS), which has been reported in clinical studies (with an incidence of <0.1%), is seen clinically at a very low frequency [20,21].
Reversible posterior leukoencephalopathy syndrome is a clinicoradiologic entity characterized by headaches, altered mental status, seizures, and visual loss and is associated with white matter vasogenic edema predominantly affecting the posterior occipital and parietal lobes of the brain.
The most serious adverse events associated with Avastin across all trials were gastrointestinal perforation, wound healing complications, hemorrhage, arterial thromboembolic events, hypertensive crisis, reversible posterior leukoencephalopathy syndrome (RPLS), neutropenia and infection, nephrotic syndrome and congestive heart failure.
The brain lesions disappeared after treatment with nitroglycerin perfusion followed by oral antihpertensive therapy, which prompted a diagnosis of reversible posterior leukoencephalopathy syndrome (RPLS).
Full browser ?